Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Welcure Drugs Pharma
Join Channel
Consolidated Standalone

Welcure Drugs&Pharma

₹5.4 0.3 | 4.9%

Market Cap ₹7 Cr.

Stock P/E 650.6

P/B 5.1

Current Price ₹5.4

Book Value ₹ 1.1

Face Value 10

52W High ₹5.5

Dividend Yield 0%

52W Low ₹ 3.2

Edit Ratio

Welcure Drugs&Pharma Research see more...

Overview Inc. Year: 1996Industry: Trading

Welcure Drugs&Pharma Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Welcure Drugs&Pharma Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0 0 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
Operating Profit -0 -0 0 -0 -0 -0 0 -0 -0 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 0 -0 -0 -0 0 -0 -0 -0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax -0 -0 0 -0 -0 -0 0 -0 -0 -0
Adjustments 0 0 0 0 0 0 0 0 0 -0
Profit After Adjustments -0 -0 0 -0 -0 -0 0 -0 -0 -0
Adjusted Earnings Per Share -0 -0 0.1 -0 -0 -0 0.1 -0 -0.1 -0

Welcure Drugs&Pharma Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit 0 0 0 0 0 -0 0 -0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 -0 0 -0 0 0 0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 -0 0 -0 0 0 0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 -0 0 -0 0 0 0 0
Adjusted Earnings Per Share 0 0 0 0.1 0 -0 0 -0 0 0 0.1 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 38% 31% 68% 21%
ROE Average 13% 58% 28% 17%
ROCE Average 13% 58% 29% 17%

Welcure Drugs&Pharma Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds -0 -0 -0 0 0 0 0 0 0 0 2
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 0 0 0 0 0 0 0 0 0 0 2
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0 0 0 0 0 0 1
Total Current Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 0 0 0 0 0 0 0 0 0 0 2

Welcure Drugs&Pharma Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 0 -0 0 -0 0 -0 0 -0 0 0 0
Cash Flow from Investing Activities 0 -0 -0 0 0 0 0 0 0 0 1
Cash Flow from Financing Activities 0 0 0 0 0 0 0 0 0 0 -1
Net Cash Inflow / Outflow 0 -0 0 -0 0 -0 0 -0 0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Welcure Drugs&Pharma Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.01 0 0 0.07 0.02 -0.02 0 -0.01 0.05 0.02 0.08
CEPS(Rs) 0.01 0 0 0.07 0.02 -0.02 0 -0.01 0.05 0.02 0.08
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) -0.07 -0.07 -0.06 0.01 0.03 0.02 0.02 0.01 0.06 0.08 1.13
Core EBITDA Margin(%) -25.25 -27.09 6.9 32.43 30.86 -41 2.91 -11.64 41.26 22.52 0
EBIT Margin(%) 39.59 7.97 11.65 85.65 30.86 -38.6 4.99 -11.27 41.42 22.52 0
Pre Tax Margin(%) 39.48 7.81 11.58 85.59 30.77 -38.8 4.88 -11.39 41.36 22.46 0
PAT Margin (%) 39.48 7.81 11.58 85.59 30.77 -38.8 4.88 -11.39 41.36 22.46 0
Cash Profit Margin (%) 39.48 7.81 11.58 85.59 30.77 -38.8 4.88 -11.39 41.36 22.46 0
ROA(%) 29.03 5.68 10.4 227.41 94.5 -58.62 14.57 -34.54 112.99 27.77 12.51
ROE(%) 0 0 0 0 108.61 -65.8 17.83 -49.46 131.74 29.03 12.65
ROCE(%) 0 0 0 0 108.91 -65.46 18.22 -48.94 131.94 29.12 12.67
Receivable days 0 0 0 0 0 0 0 0 0 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 152.21 516.67 302.08 25.53 176.27 0 165.62 0 41.32 501.03 53.1
Price/Book(x) -23.56 -18.84 -23.78 188.06 124.07 0 27.09 33.9 32.82 127.31 3.57
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 58.65 38.66 33.61 21.79 53.98 242.12 7.89 5.81 16.73 112.13 0
EV/Core EBITDA(x) 148.15 485.26 288.43 25.45 174.93 -627.25 158.27 -51.55 40.39 497.89 51.4
Net Sales Growth(%) 0 16.04 34.48 97.05 -10.27 -44.19 59 3.77 61.63 -21.26 -100
EBIT Growth(%) 112.56 -76.65 96.68 1348.53 -67.67 -169.81 120.54 -334.64 693.92 -57.19 330.78
PAT Growth(%) 112.47 -77.03 99.34 1356.22 -67.74 -170.37 119.99 -342.39 686.68 -57.24 331.41
EPS Growth(%) 112.47 -77.31 100 1369.09 -67.74 -170.33 120 -343.74 683.33 -57.14 288.21
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 0.38 0.4 0.45 3.93 11.83 6.5 4.88 2.39 20.33 17.3 0.43
Quick Ratio(x) 0.38 0.4 0.45 3.93 11.83 6.5 4.88 2.39 20.33 17.3 0.43
Interest Cover(x) 353.15 51.93 166.3 1357.44 358.1 -193 46.36 -93 636.34 346.74 703.02
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Welcure Drugs&Pharma Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 14.12 14.12 14.12 0 0 0 0 0 0 0
FII 0 0 0 0 0 0 0 0 0 0
DII 0.01 0.01 0.01 0.01 0.01 0.01 0 0 0 0
Public 85.86 85.86 85.86 99.99 99.99 99.99 100 100 100 100
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 58%
  • Company is almost debt free.

Cons

  • Promoter holding is low: 0%.
  • Stock is trading at 5.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Welcure Drugs&Pharma News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!